Lace(lomustine, ARA-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity

被引：0
|
作者：
Orchard, K
Lyttelton, MP
Abrahamson, G
Stem, S
Abboudi, Z
McGuigan, D
Giles, C
Kanfer, EJ
Samson, D
机构：
[1] CHARING CROSS HOSP,LONDON,ENGLAND
[2] HAMMERSMITH HOSP,LONDON,ENGLAND
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：969 / 969
页数：1
相关论文
共 50 条
  • [21] THE COMPARISON OF BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C AND MELPHALAN) AND BEAM (BCNU, ETOPOSIDE, ARA-C AND MELPHALAN) CONDITIONING REGIMENS IN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
    Mikhailova, N.
    Kondakova, E.
    Maramy-Zonouzi, N.
    Bondarenko, S.
    Podoltseva, E.
    Medvedeva, N.
    Popova, M.
    Ryabchikova, V.
    Afanasiev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S448 - S449
  • [22] Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation
    Wäsch, R
    Reisser, S
    Hahn, J
    Bertz, H
    Engelhardt, M
    Kunzmann, R
    Veelken, H
    Holler, E
    Finke, J
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (03) : 243 - 250
  • [23] A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation
    Thornley, L
    Lehmann, LE
    Sung, L
    Holmes, C
    Spear, HM
    Brennan, L
    Vangel, M
    Bechard, L
    Richardson, P
    Duggan, C
    Guinan, EC
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (09) : 635 - 644
  • [24] Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation
    R Wäsch
    S Reisser
    J Hahn
    H Bertz
    M Engelhardt
    R Kunzmann
    H Veelken
    E Holler
    J Finke
    [J]. Bone Marrow Transplantation, 2000, 26 : 243 - 250
  • [25] Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors
    Gupta, Alok
    Gokarn, Anant
    Rajamanickam, Deepan
    Punatar, Sachin
    Thippeswamy, Ravi
    Mathew, Libin
    Bagal, Bhausaheb
    Kannan, Sadhana
    Khattry, Navin
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (05) : 926 - 933
  • [26] Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
    Leal, Christianne Toledo de Souza
    Costa, Luciano Jose Megale
    Pereira, Juliana
    Duarte, Fernando Barroso
    Tavares, Raphael Barros
    Atalla, Angelo
    Sabioni, Bruna Sousa
    Neto, Abrahao Elias Hallack
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 309 - 311
  • [27] Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
    Nathan, Sunita
    Jimenez, Antonio M.
    Moreno, Alfonso D.
    Maciejewski, John
    Fung, Henry C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S143 - S144
  • [28] Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
    Christianne Tolêdo de Souza Leal
    Luciano José Megale Costa
    Juliana Pereira
    Fernando Barroso Duarte
    Raphael Barros Tavares
    Angelo Atalla
    Bruna Sousa Sabioni
    Abrahão Elias Hallack Neto
    [J]. Bone Marrow Transplantation, 2022, 57 : 309 - 311
  • [29] Autologous peripheral blood progenitor cell transplantation in relapsed germ cell tumours; A novel conditioning regimen containing paclitaxel is well tolerated and causes little regimen-related toxicity.
    Stern, SCM
    Giles, C
    Olavarria, E
    Samson, D
    Seckl, M
    Newlands, ES
    Kanfer, EJ
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S231 - S231
  • [30] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    [J]. BLOOD, 2017, 130
12345